CLINICAL_TRIALS
research
· 2026-02-13
Clinical Trial Update: A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus [Phase 3]
Summary
A Phase 3 clinical trial of MIL62 for systemic lupus erythematosus is listed as not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: NOT_YET_RECRUITING